Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 16137 articles
Comparison of perioperative chemotherapy and neoadjuvant chemoradiotherapy (CRT) in locally advanced resectable distal esophageal/esophagogastric junction (EGJ) adenocarcinomas
Treatment modality not independent predictor of OS.
»
05/18/26
Comparative study between PET-CT simulation and CT for head and neck cancer treatment and their potential effect on the thyroid gland: a prospective comparative study
PET-CT simulation demonstrated significant improvement in GTVp delineation accuracy.
»
05/18/26
P53 - a new player in the metabolic adaptation of colorectal carcinoma cells under hypoxia
Severe hypoxia stabilized p53 protein levels.
»
05/19/26
Cryoablation for early-stage invasive breast cancer: pathologic and imaging outcomes from the prospective FIRST trial
MRI demonstrated high predictive accuracy for complete response.
»
05/19/26
Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity
IFN-γ produced by NK cells sufficient to induce PD-L1 upregulation.
»
05/19/26
Outcome of patients with lung cancer treated with stereotactic body radiotherapy for bone oligometastases - a European multicenter cohort study
SBRT of BoM from NSCLC effective and well-tolerated treatment.
»
05/19/26
A population-based study on the impact of social determinants of health on time to treatment of stage I lung cancer in Ontario, Canada
Increased time to treatment significantly associated with advanced age.
»
05/20/26
Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis
Extramedullary disease adversely prognostic.
»
05/20/26
Epitranscriptomic silencing of the ZC3H13/m6A axis orchestrates immunosuppressive microenvironment remodeling in renal cell carcinoma via CSF2-mediated MDSCs recruitment
Therapeutic targeting CSF2 in combination with anti-PD1 exerts stronger antitumor effects.
»
05/20/26
Safety and efficacy of PD-1/PD-L1 inhibitors combined with albumin-bound paclitaxel and fluorouracil-based agents as second-line therapy in biliary tract cancers
Most common grade 3–4 TRAEs chemotherapy-related.
»
05/20/26
< Prev
Next >